Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adelaida La Casta, MD
Hospital Donostia
Principal Investigator - Andrés Muñoz, MD
COMPLEJO HOSPITALARIO GREGORIO MARAÑÓN
Principal Investigator - Carmen Guillén, MD
Hospital Universitario Ramon y Cajal
Principal Investigator - Fernando Rivera, MD
HOSPITAL UNIVERSITARIO MARQUÉS DE VELDECILLA
Principal Investigator - Inmaculada Alés, MD
COMPLEJO HOSPITALARIO REGIONAL DE MÁLAGA
Principal Investigator - Javier Sastre, MD
Hospital San Carlos, Madrid
Principal Investigator - Joaquina Martínez, MD
COMPLEJO HOSPITALARIO REGIONAL VIRGEN DE LAS NIEVES
Principal Investigator - José I Martín, MD
HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DIAZ
Principal Investigator - Manuel Hidalgo, MD
Hospital Universitario Madrid Sanchinarro
Study Chair - Manuel Valladares, MD
COMPLEXO HOSPITALARIO UNIVERSITARIO A CORUÑA
Principal Investigator - Rafael López, MD
COMPLEXO HOSPITALARIO UNIVERSITARIO DE SANTIAGO
Principal Investigator - Roberto P Díaz, MD
Hospital Universitario La Fe
Principal Investigator - Roberto Pazo, MD
Hospital Miguel Servet
Principal Investigator - Rut Vera, MD
Complejo Hospitalario de Navarra
Principal Investigator - Teresa Macarulla, MD
Hospital Vall d'Hebron
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Complexo Hospitalario Universitario A Coruña
A Coruña, A Coruña, Spain
- Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, A Cosuña, Spain
- Hospital Universitari Vall D'Hebron
Barcelona, Barcelona, Spain
- Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
- Hospital Universitario Donostia
Donostia / San Sebastian, Gipuzkoa, Spain
- Complejo Hospitalario Regional Virgen de Las Nieves
Granada, Granada, Spain
- Complejo Hospitalario Gregorio Marañón
Madrid, Madrid, Spain
- Hospital Clínico San Carlos
Madrid, Madrid, Spain
- Hospital Ramón Y Cajal
Madrid, Madrid, Spain
- Hospital Universitario Fundación Jiménez Díaz
Madrid, Madrid, Spain
- Hospital Universitario Madrid Sanchinarro
Madrid, Madrid, Spain
- Complejo Hospitalario Regional de Málaga
Málaga, Málaga, Spain
- Complejo Hospitalario de Navarra
Pamplona, Navarre, Spain
- Hospital Universitari I Politècnic la Fe
Valencia, Valencia, Spain
- Hospital Universitario Miguel Servet
Zaragoza, Zaragoza, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2013
- Primary completion
- 30 Apr 2016
- Completion
- 30 Apr 2016
- Last update posted
- 6 Jul 2016
- Registered enrollment
- 224
- Registry id
- NCT02382263
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.